AskBio Announces Initiation of Phase 2 GenePHIT Trial in Congestive Heart Failure (CHF) Research Triangle Park, N.C., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer...